Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mind Medicine Mindmed Inc
(NQ:
MNMD
)
5.850
-0.040 (-0.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mind Medicine Mindmed Inc
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 18, 2023
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.
Via
Benzinga
Psychedelic Compound-Based Drug Stocks Up 12% MTD; Now Up 25% YTD
July 14, 2023
Our Psychedelic Drug Stocks Index is up 12.3% MTD and is now up 25.1% YTD.
Via
Talk Markets
Psychedelic Stocks Jumped 10% Last Week
July 09, 2023
The FDA released a positive draft guidance for developing psychedelic treatments and the 6 largest stocks in the Psychedelic Drug Stocks Index responded accordingly
Via
Talk Markets
The Latest Analyst Ratings for Mind Medicine
June 28, 2023
Via
Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
July 04, 2023
World's Largest Psychedelics Conference Boasts 12K Attendees
Via
Benzinga
Upward Trend In Largest Psychedelic Compound-Based R&D Stocks Continues
July 01, 2023
Our Psychedelic Drug Stocks Index, which consists of the 6 largest psychedelic compound-based research & development companies, was up 3.4% this week, up 7.1% in June, up 6.3% in May, and is now up...
Via
Talk Markets
The 3 Best Psychedelic Stocks to Buy Now
June 29, 2023
Psychedelic stocks promise to bring therapeutics to market that were taboo until recently and have huge upside.
Via
InvestorPlace
MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld
June 27, 2023
MindMed’s (NASDAQ: MNMD) heated proxy battle over R&D strategy might finally be coming to an end.
Via
Benzinga
FCM Received Significant Support from Shareholders, Disappointed that “Passive” Investors Saw Fit to Give Incumbent Directors Another Chance to Disappoint
June 22, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
MindMed to Participate in the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference
June 22, 2023
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Announces Election of All Six Company Nominees at Annual Meeting
June 21, 2023
From
Mind Medicine
Via
Business Wire
MindMed Provides Overview of Clinical Progress and Corporate Updates at Investor Day
June 20, 2023
From
Mind Medicine
Via
Business Wire
Upward Trend In Major Psychedelic Compound-Based Research & Development Stocks Continue
June 17, 2023
There are 6 constituents in our munKNEE Psychedelic Drug Stocks Index and 5 of them advanced this week and are now all up MTD.
Via
Talk Markets
FCM Denounces MindMed’s Manipulation of Corporate Machinery to Protect Incumbent Board of Directors
June 15, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
MindMed Adjourns Annual General Meeting of Shareholders
June 15, 2023
From
Mind Medicine
Via
Business Wire
Major Psychedelic Compound-Based Research & Development Stocks: June Update
June 10, 2023
Psychedelic Drug Stocks Index has been revamped with the removal of Cybin (CYBN) which has dropped below $100M in market capitalization leaving 6 constituents in the Index
Via
Talk Markets
Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia
June 09, 2023
Australia-based cannabis and psychedelics company Creso Pharma Ltd. (OTCMKTS: COPHF) inked a Letter of Intent (LOI) with Swiss pharmacy Apotheke Dr.
Via
Benzinga
MindMed Urges Shareholders to Vote TODAY for Company Nominees Ahead of June 13th Deadline
June 09, 2023
From
MindMed
Via
Business Wire
Leading Proxy Advisory Firm Glass Lewis Recommends MindMed Shareholders Vote FOR All Six Company Nominees
June 08, 2023
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
FCM Plans for MM-120 (LSD) FDA Approval in 2026 And Extends Share Lockup Until June 15, 2026
June 07, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
MindMed to Host Investor Day June 2023
June 07, 2023
From
Mind Medicine
Via
Business Wire
Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study
June 05, 2023
Mental healthcare company Numinus Wellness (OTCQX: NUMIF) announced its contract research organization Cedar Clinical Research (CCR) is a top research site for MindMed's (NASDAQ: MNMD) Phase 2b stud
Via
Benzinga
Leading Proxy Advisory Firm ISS Recommends MindMed Shareholders Vote FOR All Six Company Nominees
June 05, 2023
From
MindMed
Via
Business Wire
FCM Predicts Psychedelic Revolution In 2024: Urges Shareholders to Position MindMed for Success with a Reconstituted Board
June 02, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
May Summary Of Largest Psychedelic Compound-Based Drug Stock Performances
June 01, 2023
Only two of the seven largest psychedelic compound-based drug stocks tracked, advanced in May.
Via
Talk Markets
MindMed to Participate at Upcoming Investor Conferences
June 01, 2023
From
Mind Medicine
Via
Business Wire
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
May 31, 2023
Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics...
Via
Benzinga
FCM Pledges to Lock Up its MindMed Shares Until June 2025 to Demonstrate its Alignment with Fellow Shareholders and Confidence in its Plan to Restore MindMed
May 30, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
MindMed And FCM Holdings' Dispute Over Clinical Path Forward Deepens
May 30, 2023
The proxy battle over MindMed’s (NASDAQ: MNMD) control has now evolved to each side requesting their position on what is best for the company's future to be validated by independent sources, vis-a-vis...
Via
Benzinga
FCM Concerned MindMed’s Mismanagement Threatens Mental Health for Millions
May 25, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.